Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in the elderly.

George S Alexopoulos1

  • 1Weill Medical College of Cornell University and Weill-Cornell Institute of Geriatric Psychiatry, 21 Bloomingdale Road, White Plains, New York, NY 10605, USA. gsalexop@med.cornell.edu

Lancet (London, England)
|June 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Dialectic View of Late-life.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same author

Effect of continuation treatment on health-related quality of life in remitted psychotic depression.

Journal of affective disorders·2026
Same author

Beyond the biological decline of aging: The evolution of critical phenomenology.

International psychogeriatrics·2026
Same author

Beyond the biological decline of aging: From phenomenology to 4E cognitive science.

International psychogeriatrics·2026
Same author

Clozapine in Older Adults: Benefits and Challenges.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same author

Decline of Aging: Aesthetics and Ethics of Care.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Late-life depression significantly impacts older adults, especially those with chronic illnesses. Effective treatments exist, but inadequate insurance coverage in North America hinders access to care for elderly depression.

Area of Science:

  • Gerontology
  • Psychiatry
  • Neuroscience

Background:

  • Late-life depression is prevalent in elderly individuals with chronic medical conditions and cognitive impairment.
  • It leads to significant suffering, disability, family disruption, and increased mortality.
  • Ageing and disease processes affect brain regions crucial for mood regulation, increasing vulnerability.

Purpose of the Study:

  • To review the impact of depression in the elderly.
  • To discuss the biological and psychosocial factors contributing to late-life depression.
  • To evaluate current treatment and prevention strategies for elderly depression.

Main Methods:

  • Literature review of studies on late-life depression.
  • Analysis of biological mechanisms (arteriosclerosis, inflammation, endocrine/immune changes) affecting brain pathways.

Related Experiment Videos

  • Examination of psychosocial adversity factors (poverty, isolation, bereavement).

    • Main Results:

    • Antidepressant treatment is well-tolerated and effective in older adults, comparable to younger populations.
    • Evidence-based guidelines and care systems for prevention and treatment are available.
    • Inadequate public insurance coverage in North America limits access to these services.

    Conclusions:

    • Depression in the elderly is a serious condition influenced by biological and psychosocial factors.
    • Effective interventions exist, but healthcare access remains a challenge due to insufficient insurance coverage.
    • Improving access to care is crucial for managing and preventing depression in older adults.